EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia

Jolene Yin Ling Fu iD, Muhammad Harith Pukhari, Maria Kahar Bador, I-Ching Sam, Yoke Fun Chan iD

Viruses · 2023

DOI: 10.3390/v15040844 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Viruses, 2023. Verfasst von Jolene Yin Ling Fu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia. Hauptthemen laut MEDLINE: BNT162 Vaccine, COVID-19. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education, Malaysia, Universiti Malaya.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaccine efficacy against SARS-CoV-2 could be compromised by the emergence of SARS-CoV-2 variants and it is important to study how it impacts the booster vaccination regime. We investigated the humoral and T cell responses longitudinally in vaccinated uninfected (n = 25) and post-COVID-19 individuals (n = 8), and those who had received a BNT162b2 booster following complete two-doses regimes of either BNT162b2 (homologous) (n = 14) or ChAdOx1-S (heterologous) (n = 15) vaccines, by means of a SARS-CoV-2 pseudovirus neutralization test and QuantiFERON SARS-CoV-2 assay. Vaccinated post-COVID-19 individuals showed higher neutralizing antibodies with longer durability against SARS-CoV-2 wild type (WT) and Omicron spikes, but demonstrated similar declining T cell responses compared to the uninfected vaccinated. Two doses of BNT162b2 induced higher neutralizing antibodies against WT and T cell responses than ChAdOx1-S for six months. The BNT162b2 booster confers a greater humoral response against WT, but a similar cross-neutralizing antibody against Omicron and T cell responses in the homologous booster group compared to the heterologous booster group. Breakthrough infection in the homologous booster group (n = 11) significantly increased the neutralizing antibody, but T cell responses remained low. Our data may impact government public health policy regarding the administration of mix-and-match vaccines, where both vaccination regimes can be employed should there be shortages of certain vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BNT162 VaccineCOVID-19HumansLongitudinal StudiesSARS-CoV-2Breakthrough InfectionsMalaysiaT-LymphocytesCohort StudiesAntibodies, NeutralizingChAdOx1 nCoV-19VaccinationAntibodies, Viral

Stichwörter der Autor:innen

BNT162b2 vaccineChAdOx1-S vaccineOmicronSARS-CoV-2T cell responsesboosterneutralizing antibody

Substanzen

BNT162 VaccineAntibodies, NeutralizingChAdOx1 nCoV-19Antibodies, Viral

Autor:innen und Institutionen

  • Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.
  • Department of Medical Microbiology, University Malaya Medical Centre, Kuala Lumpur 59100, Malaysia.

ORCID-Profile: Jolene Yin Ling Fu, Yoke Fun Chan

Förderung

  • Ministry of Higher Education, Malaysia
  • Universiti Malaya

Zitieren

APA

Fu, J. Y. L., Pukhari, M. H., Bador, M. K., Sam, I. C., & Chan, Y. F. (2023). Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia. Viruses. https://doi.org/10.3390/v15040844

Vancouver

Fu JYL, Pukhari MH, Bador MK, Sam IC, Chan YF. Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia. Viruses. 2023. doi:10.3390/v15040844

BibTeX
@article{Fu2023,
  author = {Fu, Jolene Yin Ling and Pukhari, Muhammad Harith and Bador, Maria Kahar and Sam, I-Ching and Chan, Yoke Fun},
  title = {Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15040844}
}
Kostenlos starten →